Image credit: Houston Methodist
Researchers at Houston Methodist Research Institute have created a nanodevice that can be used to deliver immunotherapy to treat triple-negative breast cancer.
The tiny device is designed to be inserted directly into a tumor, delivering a localized, sustained-release dose of therapy and eliminating the need for patients to undergo IV treatments.
Get the full story at our sister site, Drug Delivery Business News.
The post Researchers develop nanodevice to deliver immunotherapy appeared first on MassDevice.